fda semaglutide obesity Live Updates on Semaglutide's Current and Future Uses FDA approves Novo Nordisk's oral

PlexusDx provides compounded semaglutide injections from licensed pharmacies for $149/mono insurance approval delays, no membership fees, and HSA/FSA eligible

Shanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting competition in a...

Despite what the media reported, the FDA's new green list doesnt affect legitimate compounders.

Powered by data from Ro's nationwide platform, the research will evaluate the real-world challenges that patients and providers must navigate in order to access and deliver evidence-based obesity care.

In a surprising twist, Hollywoods finest are reportedly flocking to restaurants in search of Ozempic meals. According to an anonymous talent agent, the trend has emerged as a result of...

your doctor will advise if your specific medications require adjustment